The pharma industry needs to measure patient experience from the patients’ perspectives

first_img [email protected] By Hensley Evans and Sharon Suchotliff May 10, 2021 Reprints The relationship between clinical outcomes and the patient experience — the sum of all of interactions of an individual related to managing his or her health — has long been established and documented.Yet many elements that are typically described as having an impact on overall experience are related to quality of care and the patient-physician relationship, things largely outside the control of pharmaceutical companies. So how do pharma programs, which can include patient support services, direct-to-consumer advertising, and collaborations with patient advocacy groups, among other things, contribute to the patient experience? Tags drug developmentpatientsresearchSTAT+ Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. linkedin.com/in/sharonmsuchotliff Log In | Learn More GET STARTED STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. What’s included? What is it?center_img linkedin.com/in/hensleyevans/ Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Opinions+ Hensley Evans Sharon Suchotliff About the Authors Reprints [email protected] Adobe The pharma industry needs to measure patient experience from the patients’ perspectives last_img read more